Abstract:Abstract Introduction Radiofrequency ablation (RFA) has been studied in solitary and reoccurring/ persistent papillary thyroid cancer (PTC) with favorable results. This case describes a patient with reoccurring PTC who underwent radiofrequency ablation. Clinical Case This is a case of a 68 year old male who was underwent an elective thyroid surgery for compressive multinodular goiter and left inferior parathyroid adenoma. Prior to his surgery he had fine needle aspiration cytologies of multiple nodules that were negative for thyroid cancer. A total thyroidectomy with excision of central cervical lymph nodes, excision of a suspicious right perithyroidal mass and a left inferior parathyroidectomy were performed. The pathology diagnosis was multifocal bilateral papillary thyroid cancer – classical type – with infiltration into perithyroidal adipose tissue and lymph node metastasis (pathological stage: mpT1b pN1a). Serum thyroglobulin was 4.9 ng/mL (reference range 1.6–59.9 ng/mL). Postoperatively, he was given adjuvant radioactive iodine (I-131 120mCi) treatment and suppressive levothyroxine at 250 μg daily, with pretreatment TSH at 14.730 μU/mL and TSH after 4 months of treatment 0.140 μU/mL. Single photon emission computed tomography (SPECT) whole body imaging done seven days post radioactive iodine therapy showed no evidence of distant metastases. Four months after I-131 therapy, a diagnostic ultrasound for a palpable node revealed this to be a right level IIb cystic cervical lymph node (18×16×18 mm) with no overt vascularity. Serum thyroglobulin was <0.2 ng/mL and thyroglobulin antibodies were <14.4 IU/mL. FNA biopsy, with cytology showing papillary thyroid cancer. Needle washout thyroglobulin was elevated (1015.3 ng/mL, reference range < 10ng/mL). This metastatic lymph node was concluded to be recurrent papillary cancer. Surgical dissection and percutaneous alternatives were discussed with the patient. Shared decision making between surgery, intervention radiology and the patient concluded that a less invasive procedure was preferred and the solitary node was a candidate for percutaneous ablation. Post ablation surveillance ultrasonography showed an 80% volume reduction (11×8×12 mm) in node size six weeks post intervention and a 95% volume reduction at six months (8×5×7 mm), with decreased cystic appearance and no vascularity. No complications were reported after the procedure. Conclusion Current guidelines recommend that the mainstay of recurrent thyroid cancer is surgery, followed by radioactive iodine therapy and suppressive thyroid hormone replacement treatment, external beam radiotherapy and/ or chemotherapy. However within recent years, image guided ablation techniques such as radiofrequency ablation has been explored and has become an alternative in selective who wish to avoid extensive lymph node dissection. Multiple studies unanimously report a node volume reduction rate (VRR) of greater than 50%, with some studies reporting almost 99% VRR within 12-24 months; suggesting a role for RFA to replace 'berry picking surgery' in selected patients. Presentation: No date and time listed

Pseudoaneurysm of Superior Thyroid Artery Following Ultrasound-Guided Radiofrequency Ablation of Hyperplastic Parathyroid Gland: a Case Report and Literature Review.

US-Guided Percutaneous Microwave Ablation for Primary Hyperparathyroidism with Parathyroid Nodules: Feasibility and Safety Study.

Post-surgical Persistent Hyperparathyroidism Successfully Treated with Parathyroid Radiofrequency Ablation: A Case Report

Regression of Calcinosis Following Treatment with Radiofrequency Thermoablation for Severe Secondary Hyperparathyroidism in a Hemodialysis Patient

Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience

Iatrogenic thyroid pseudoaneurysm following thyroid nodule radiofrequency ablation

Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study

Efficacy of Ablation Therapy for Secondary Hyperparathyroidism by Ultrasound Guided Percutaneous Thermoablation.

Severe secondary hyperparathyroidism in a chronic kidney disease patient treated with Radiofrequency ablation: One case report

Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism

Ultrasound-guided thermal ablation for hyperparathyroidism: current status and prospects

Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Primary Hyperparathyroidism: A Prospective Study

Ultrasound-Guided Radiofrequency Ablation in Tertiary Hyperparathyroidism: A Prospective Study

Percutaneous Ultrasound-Guided Laser Ablation with Contrast-Enhanced Ultrasonography for Hyperfunctioning Parathyroid Adenoma: A Preliminary Case Series

Effectiveness And Safety Of Thermal Ablation In The Treatment Of Primary Hyperparathyroidism: A Multicenter Study

Ultrasound-Guided Radiofrequency Ablation for Primary Hyperparathyroidism Induced by Multiple Endocrine Neoplasia 1—A Case Report

PSAT280 Role of Radiofrequency Ablation Therapy in Recurrent Papillary Thyroid Carcinoma - A Case Study

Ultrasound-guided radiofrequency ablation for the treatment of papillary thyroid carcinoma: a review of the current state and future perspectives

Radiofrequency ablation as a treatment modality for primary hyperparathyroidism: a systematic literature review

Radiofrequency ablation of parathyroid gland as a treatment modality for primary hyperparathyroidism – A novel bedside procedure in critically ill patients

Comparison of Microwave Ablation Treatments in Patients with Renal Secondary and Primary Hyperparathyroidism.